TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹1,656 Cr | ₹1,245 Cr | ₹777 Cr | ₹1,252 Cr | ₹1,025 Cr |
What is the latest Consolidated Net Profit of TORRENT PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹1,656 Cr |
| Mar2024 | ₹1,245 Cr |
| Mar2023 | ₹777 Cr |
| Mar2022 | ₹1,252 Cr |
| Mar2021 | ₹1,025 Cr |
How is Consolidated Net Profit of TORRENT PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,656 Cr | 33.02 | |
| Mar2024 | ₹1,245 Cr | 60.22 | |
| Mar2023 | ₹777 Cr | -37.92 | |
| Mar2022 | ₹1,252 Cr | 22.17 | |
| Mar2021 | ₹1,025 Cr | - | |
Compare Consolidated Net Profit of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹128,602.2 Cr | -0.8% | 0.8% | 12.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,708.0 Cr | -2.7% | -2.2% | -0.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,975.0 Cr | -0.7% | -1.1% | 7.6% | Stock Analytics | |
| CIPLA | ₹122,539.0 Cr | -1.2% | -1.8% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,741.0 Cr | NA | 2.4% | 0.2% | Stock Analytics | |
| MANKIND PHARMA | ₹89,743.8 Cr | -1.7% | -3.6% | -21.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -0.8% |
0.8% |
12.2% |
| SENSEX | -0.4% |
-0.3% |
3.9% |
You may also like the below Video Courses